|
|
|
|
LEADER |
01000naa a22002652 4500 |
001 |
NLM201971569 |
003 |
DE-627 |
005 |
20231223223435.0 |
007 |
cr uuu---uuuuu |
008 |
231223s2010 xx |||||o 00| ||eng c |
024 |
7 |
|
|a 10.1016/j.clim.2010.08.013
|2 doi
|
028 |
5 |
2 |
|a pubmed24n0673.xml
|
035 |
|
|
|a (DE-627)NLM201971569
|
035 |
|
|
|a (NLM)20884299
|
040 |
|
|
|a DE-627
|b ger
|c DE-627
|e rakwb
|
041 |
|
|
|a eng
|
100 |
1 |
|
|a Ferreyra Solari, Nazarena E
|e verfasserin
|4 aut
|
245 |
1 |
4 |
|a The simultaneous high expression of Vα24, IFN-γ and FoxP3 characterizes the liver of children with type I autoimmune hepatitis
|
264 |
|
1 |
|c 2010
|
336 |
|
|
|a Text
|b txt
|2 rdacontent
|
337 |
|
|
|a ƒaComputermedien
|b c
|2 rdamedia
|
338 |
|
|
|a ƒa Online-Ressource
|b cr
|2 rdacarrier
|
500 |
|
|
|a Date Completed 26.11.2010
|
500 |
|
|
|a Date Revised 25.03.2021
|
500 |
|
|
|a published: Print-Electronic
|
500 |
|
|
|a Citation Status MEDLINE
|
520 |
|
|
|a Copyright © 2010 Elsevier Inc. All rights reserved.
|
520 |
|
|
|a The immunopathogenesis of type I autoimmune hepatitis (AIH-I) might involve the deregulation of different cellular processes. Here, we investigated the liver expression of selected cytokines and genes of regulatory cell populations in children both at diagnosis and during biochemical remission following immunosuppressive treatment (AIH-Ir). We found a higher Vα24, IFN-γ, FoxP3, IL-27p28, IL-12p40 and IL-21 expression at diagnosis as well as a positive correlation between IL-21 and transaminase levels. Interestingly, only IFN-γ and FoxP3 were decreased in AIH-Ir. An "AIH-I phenotype" (high Vα24, IFN-γ and FoxP3 expression at diagnosis) was observed in only 5 out of 22 AIH-Ir patients but not in controls. These results indicate a local deregulation of the innate and adaptive immune responses with an increased transcriptional activity of immunoregulatory cells at diagnosis. In addition, IL-21 is highlighted as a mediator of liver injury. AIH-Ir is characterized by a partial reversal of the deregulated response
|
650 |
|
4 |
|a Journal Article
|
650 |
|
4 |
|a Research Support, Non-U.S. Gov't
|
650 |
|
7 |
|a Biomarkers
|2 NLM
|
650 |
|
7 |
|a FOXP3 protein, human
|2 NLM
|
650 |
|
7 |
|a Forkhead Transcription Factors
|2 NLM
|
650 |
|
7 |
|a Interleukin-12 Subunit p40
|2 NLM
|
650 |
|
7 |
|a Interleukins
|2 NLM
|
650 |
|
7 |
|a MYDGF protein, human
|2 NLM
|
650 |
|
7 |
|a RNA, Messenger
|2 NLM
|
650 |
|
7 |
|a Receptors, Antigen, T-Cell
|2 NLM
|
650 |
|
7 |
|a Valpha24 protein, human
|2 NLM
|
650 |
|
7 |
|a Interferon-gamma
|2 NLM
|
650 |
|
7 |
|a 82115-62-6
|2 NLM
|
650 |
|
7 |
|a Transaminases
|2 NLM
|
650 |
|
7 |
|a EC 2.6.1.-
|2 NLM
|
650 |
|
7 |
|a interleukin-21
|2 NLM
|
650 |
|
7 |
|a MKM3CA6LT1
|2 NLM
|
700 |
1 |
|
|a Galoppo, Cristina
|e verfasserin
|4 aut
|
700 |
1 |
|
|a Cuarterolo, Miriam
|e verfasserin
|4 aut
|
700 |
1 |
|
|a Goñi, Javier
|e verfasserin
|4 aut
|
700 |
1 |
|
|a Fernández-Salazar, Luis
|e verfasserin
|4 aut
|
700 |
1 |
|
|a Arranz, Luis E
|e verfasserin
|4 aut
|
700 |
1 |
|
|a Garrote, Jose A
|e verfasserin
|4 aut
|
700 |
1 |
|
|a Cherñavsky, Alejandra C
|e verfasserin
|4 aut
|
773 |
0 |
8 |
|i Enthalten in
|t Clinical immunology (Orlando, Fla.)
|d 1999
|g 137(2010), 3 vom: 15. Dez., Seite 396-405
|w (DE-627)NLM098196855
|x 1521-7035
|7 nnns
|
773 |
1 |
8 |
|g volume:137
|g year:2010
|g number:3
|g day:15
|g month:12
|g pages:396-405
|
856 |
4 |
0 |
|u http://dx.doi.org/10.1016/j.clim.2010.08.013
|3 Volltext
|
912 |
|
|
|a GBV_USEFLAG_A
|
912 |
|
|
|a SYSFLAG_A
|
912 |
|
|
|a GBV_NLM
|
912 |
|
|
|a GBV_ILN_11
|
912 |
|
|
|a GBV_ILN_24
|
912 |
|
|
|a GBV_ILN_350
|
951 |
|
|
|a AR
|
952 |
|
|
|d 137
|j 2010
|e 3
|b 15
|c 12
|h 396-405
|